V029-5447 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)-3-phenylpropanamide

V029-5447 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)-3-phenylpropanamide
V029-5447 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)-3-phenylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-5447
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)-3-phenylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-5447

Molecular Formula

C31H36N4O4 (C31 H36 N4 O4)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)-3-phenylpropanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-N-(2-{3-[4-(dimethylamino)phenyl]-124-oxadiazol-5-yl}ethyl)-3-phenylpropanamide

SMILES

CN(C)c(cc1)ccc1-c1noc(CCN(CCc(cc2)cc(OC)c2OC)C(CCc2ccccc2)=O)n1

InChI

InChI=1S/C31H36N4O4/c1-34(2)26-14-12-25(13-15-26)31-32-29(39-33-31)19-21-35(30(36)17-11-23-8-6-5-7-9-23)20-18-24-10-16-27(37-3)28(22-24)38-4/h5-10,12-16,22H,11,17-21H2,1-4H3

InChI Key

SKPSWYBQIABEFP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19791266

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

528.65

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.234

Distribution Coefficient, logD

5.234

Water Solubility, LogSw

-5.17

Polar Surface Area

65.016

Acid Dissociation Constant (pKa)

22.71

Base Dissociation Constant (pKb)

6.85

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

V029-5447 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V029-5447 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-5447?
Check Price and Availability of V029-5447, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-5447 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-5447
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-5447
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-5447 available by request